The DOI matches its Crossref record.
F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and Infection
Abstract
PURPOSE: F-18 fluorodeoxyglucose (FDG) may accumulate at sites of inflammation or infection, making interpretation of whole-body scans difficult in patients with cancer. METHODS: More than 650 whole-body positron emission tomographic (PET) scans performed to examine patients with cancer were reviewed to identify uptake in pulmonary infection or inflammation based on the appearance of F-18 FDG chest uptake, chest radiographs, computed tomography, or all of these. RESULTS: Ten patients had uptake in benign lung disease. Eight patients had head and neck tumors and two patients had breast cancer. Intense focal or multifocal F-18 FDG chest uptake was seen in 6 of 10 scans. This was difficult to distinguish from pulmonary metastases based on the scan appearance. However, in the remaining patients, the uptake was atypical for malignancy and displayed an apical, segmental, or lobar pattern. In all patients, the F-18 FDG lung uptake corresponded to benign radiologic changes (infiltration, consolidation, or atelectasis), and the final diagnosis was pulmonary inflammation or infection. Nine patients were asymptomatic and one patient had clinical aspiration pneumonia. Follow-up PET scans were performed in five patients to evaluate their conditions. Chest uptake disappeared completely in three patients and partially in two patients, and there were no new findings. Variable degrees of F-18 FDG chest uptake have been reported with more than 40 different benign causes. They can be classified based on the underlying mechanism into four major categories: 1) Inflammation or infection, 2) benign tumor, 3) physiologic activity, and 4) iatrogenic. Most of these false-positive cases are included in the first category. CONCLUSIONS: Pulmonary infection or inflammation might predispose patients to localized F-18 FDG chest uptake mimicking pulmonary metastases and limiting the specificity of whole-body scans performed in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Recommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
Blodgett, T. M., Meltzer, C. C., & Townsend, D. W. (2007) · Radiology · doi:10.1148/radiol.2422051113 · Cited by 387
Steenbakkers, R. J. H. M., Duppen, J. C., Fitton, I., Deurloo, K. E. I., Zijp, L. J., Comans, E. F. I., Uitterhoeve, A. L. J., Rodrigus, P. T. R., Kramer, G. W. P., Bussink, J., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.034 · Cited by 309
Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer
Swisher, S. G., Maish, M., Erasmus, J. J., Correa, A. M., Ajani, J. A., Bresalier, R., Komaki, R., Macapinlac, H., Munden, R. F., Putnam, J. B., et al. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.04.046 · Cited by 297
Swisher, S. G., Erasmus, J., Maish, M., Correa, A. M., Macapinlac, H., Ajani, J. A., Cox, J. D., Komaki, R. R., Hong, D., Lee, H. K., et al. (2004) · Cancer · doi:10.1002/cncr.20585 · Cited by 262
Metadata
- Authors
- BAKHEET, S. M., SALEEM, M., POWE, J., AMRO, A. A., LARSSON, S. G., & MAHASSIN, Z.
- Venue
- Clinical Nuclear Medicine
- Published
- 2000-04
- Volume
- 25
- Issue
- 4
- Pages
- 273-278
- ISSN
- 0363-9762 (ISSN-L)
- OpenAlex
- W2037077612
- Cited by
- 167
- References
- 0
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and Infection. https://app.cochat.ai/papers/10.1097/00003072-200004000-00007
- The paper
- BAKHEET, S. M., SALEEM, M., POWE, J., AMRO, A. A., LARSSON, S. G., & MAHASSIN, Z. (2000). F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and Infection. Clinical Nuclear Medicine. https://doi.org/10.1097/00003072-200004000-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.